Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

The EMA has started a review of Leo Pharma’s interleukin-13 inhibitor tralokinumab as an antibody therapy for atopic dermatitis, a category that is currently dominated by Sanofi and Regeneron ...

Vice president and general manager of UK & Ireland at LEO Pharma, Sarah Kleinpeter, said: “We are pleased that adolescents between 12-17 years of age living with atopic dermatitis will now have ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Bio-Techne is expected to have witnessed the stabilization of large-pharma customers and an increase in biotech customers' ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A recent survey conducted with online opinion panel LEO on behalf of the Regroupement des pharmacies de médicaments de spécialité (RPMSQ) reveals that Quebecers value that they have the ability to ...

Varadkar has been named as the Hauser Leader of the Harvard Kennedy School Center for Public Leadership for its spring ...

World leaders gather in Poland on Holocaust memorial day, Fed and ECB make rate calls, and the Year of the Snake begins ...

Listen to this article Hasbro board chair and the toymaker’s former interim CEO Richard S. Stoddart will join the Altria Group board of directors Monday, the Henrico County-based, Fortune 500 tobacco ...

Get insights into top dividend stock picks for 2025 from Barron’s Roundtable, with potential gains ranging from 19.46% to ...